|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2011-8-8
|
|
pubmed:abstractText |
The aim of this study was to investigate whether c-myc amplification in human breast cancer is associated with response to neoadjuvant chemotherapy comprising paclitaxel followed by 5-FU/epirubicin/cyclophosphamide (P-FEC).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide,
http://linkedlifedata.com/resource/pubmed/chemical/DNA Topoisomerases, Type II,
http://linkedlifedata.com/resource/pubmed/chemical/DNA topoisomerase II alpha,
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Epirubicin,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil,
http://linkedlifedata.com/resource/pubmed/chemical/HER2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Ki-67 Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/MYC protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-myc,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Progesterone,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1879-0852
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright © 2011 Elsevier Ltd. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
47
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1779-88
|
|
pubmed:meshHeading |
pubmed-meshheading:21741827-Adult,
pubmed-meshheading:21741827-Aged,
pubmed-meshheading:21741827-Analysis of Variance,
pubmed-meshheading:21741827-Antigens, Neoplasm,
pubmed-meshheading:21741827-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:21741827-Biopsy,
pubmed-meshheading:21741827-Breast Neoplasms,
pubmed-meshheading:21741827-Chemotherapy, Adjuvant,
pubmed-meshheading:21741827-Cyclophosphamide,
pubmed-meshheading:21741827-DNA Topoisomerases, Type II,
pubmed-meshheading:21741827-DNA-Binding Proteins,
pubmed-meshheading:21741827-Epirubicin,
pubmed-meshheading:21741827-Female,
pubmed-meshheading:21741827-Fluorouracil,
pubmed-meshheading:21741827-Gene Amplification,
pubmed-meshheading:21741827-Gene Expression Profiling,
pubmed-meshheading:21741827-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:21741827-Humans,
pubmed-meshheading:21741827-Immunohistochemistry,
pubmed-meshheading:21741827-In Situ Hybridization, Fluorescence,
pubmed-meshheading:21741827-Ki-67 Antigen,
pubmed-meshheading:21741827-Lymphatic Metastasis,
pubmed-meshheading:21741827-Middle Aged,
pubmed-meshheading:21741827-Neoadjuvant Therapy,
pubmed-meshheading:21741827-Neoplasm Staging,
pubmed-meshheading:21741827-Odds Ratio,
pubmed-meshheading:21741827-Oligonucleotide Array Sequence Analysis,
pubmed-meshheading:21741827-Paclitaxel,
pubmed-meshheading:21741827-Predictive Value of Tests,
pubmed-meshheading:21741827-Proto-Oncogene Proteins c-myc,
pubmed-meshheading:21741827-Receptor, erbB-2,
pubmed-meshheading:21741827-Receptors, Estrogen,
pubmed-meshheading:21741827-Receptors, Progesterone,
pubmed-meshheading:21741827-Retrospective Studies,
pubmed-meshheading:21741827-Treatment Outcome,
pubmed-meshheading:21741827-Tumor Markers, Biological,
pubmed-meshheading:21741827-Ultrasonography, Mammary
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Association between c-myc amplification and pathological complete response to neoadjuvant chemotherapy in breast cancer.
|
|
pubmed:affiliation |
Department of Breast and Endocrine Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
